471 related articles for article (PubMed ID: 17915401)
21. The Safe Medical Devices Act.
Williams MA
South Hosp; 1992; 58(2):16-7. PubMed ID: 10118188
[TBL] [Abstract][Full Text] [Related]
22. On FDA's front lines. Investigators protect public.
Stehlin D
FDA Consum; 1992 Jun; 26(5):14-9. PubMed ID: 10118933
[No Abstract] [Full Text] [Related]
23. Science and regulation. FDA's approach to regulation of products of nanotechnology.
Hamburg MA
Science; 2012 Apr; 336(6079):299-300. PubMed ID: 22517845
[No Abstract] [Full Text] [Related]
24. Recalls. FDA, industry cooperate to protect consumers.
Nordenberg T
FDA Consum; 1995 Oct; 29(8):24-7. PubMed ID: 10151838
[TBL] [Abstract][Full Text] [Related]
25. ORA's role at FDA headquarters and in the field for product recalls.
Whetstone SN
Food Drug Law J; 1998; 53(3):513-6. PubMed ID: 10346723
[No Abstract] [Full Text] [Related]
26. FDA works to reduce preventable medical device injuries.
Rados C
FDA Consum; 2003; 37(4):29-33. PubMed ID: 12971346
[No Abstract] [Full Text] [Related]
27. US and European postmarket clinical data requirements.
Donawa M
Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
[TBL] [Abstract][Full Text] [Related]
28. FDA's device inspection lacking. Two reports point to technology, staffing as key culprits.
Rhea S
Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18318369
[No Abstract] [Full Text] [Related]
29. Medical device epidemiology and surveillance: patient safety is the bottom line.
Brown SL; Bright RA; Tavris DR
Expert Rev Med Devices; 2004 Sep; 1(1):1-2. PubMed ID: 16293003
[No Abstract] [Full Text] [Related]
30. MedWatch. On lookout for medical product problems.
Ropp KL
FDA Consum; 1993 Nov; 27(9):14-7. PubMed ID: 10130376
[No Abstract] [Full Text] [Related]
31. The Feds do it again. The EMS community grows wary--and weary--of FDA intervention.
Nordberg M
Emerg Med Serv; 1995 Mar; 24(3):40-52. PubMed ID: 10140757
[No Abstract] [Full Text] [Related]
32. Two-page FDA form eases device-act compliance.
Benson JS
Health Facil Manage; 1992 Feb; 5(2):40-7. PubMed ID: 10116138
[No Abstract] [Full Text] [Related]
33. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
Scott B
Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
[TBL] [Abstract][Full Text] [Related]
34. MedWatch: the FDA medical products reporting program.
Rheinstein PH
Am Fam Physician; 1993 Sep; 48(4):636-8. PubMed ID: 8379493
[No Abstract] [Full Text] [Related]
35. Safe Medical Devices Act: reporting rules face hurdle.
Shepherd M; Furst E
Health Facil Manage; 1996 Apr; 9(4):38. PubMed ID: 10156096
[No Abstract] [Full Text] [Related]
36. Feds focus on medical devices.
Goldfarb B; Wolfberg D
JEMS; 1992 Jul; 17(7):35-8, 45-7. PubMed ID: 10120068
[No Abstract] [Full Text] [Related]
37. The preemptive scope of the Medical Device Amendments of 1976.
Sunshine PH
Food Drug Law J; 1995; 50(1):191-212. PubMed ID: 10342991
[No Abstract] [Full Text] [Related]
38. AHA comments to FDA on Safe Devices Act.
DePorter J
Mater Manag Health Care; 1992 Apr; 1(2):18-21. PubMed ID: 10125489
[No Abstract] [Full Text] [Related]
39. FDA's revitalization of medical device review and regulation.
Kessler DA
Biomed Instrum Technol; 1994; 28(3):220-6. PubMed ID: 8061717
[No Abstract] [Full Text] [Related]
40. Case studies on mechanical ventilator innovations: perspectives of two clinicians.
Hess D; Branson R
Respir Care; 1995 Sep; 40(9):957-67. PubMed ID: 10152240
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
